Latest filing published 11 Mar 2024 for Century Therapeutics, Inc..
Insider track record
Hyam Levitsky: trading record in brief
Filings by Hyam Levitsky span 3 companies, the busiest being Juno Therapeutics, Inc., Agenus Inc and Century Therapeutics, Inc. In total, 7 filings cover trades dated from 27 February 2009 to 7 March 2024.
No open-market purchase appears, only 2 sales worth €472k. Outside the open market, there are 4 share grants and 1 option exercise.
Most recently, on 11 March 2024, the filings show a share grant in Century Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Hyam Levitsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,000 shares0Common StockSEC:0001062993-24-006181:0
- 14,634 shares0Common StockSEC:0001209191-17-009299:0
- 12,118 shares@ US$42.7642.2% of flowCommon StockSEC:0001209191-16-129048:0
- 300 shares@ US$43.201.1% of flowCommon StockSEC:0001209191-16-129048:1
- 16,454 shares@ US$42.0456.7% of flowCommon StockSEC:0001209191-16-124174:0
- 145,000 shares0Common StockSEC:0001209191-15-048520:0
- 15,376 sharesCommon StockSEC:0001288123-09-000022:0
7 of 7 declarations
